(+)-Epijuvabione

Details

Top
Internal ID 876d6dfb-61d5-4e1e-8946-6689e28064b9
Taxonomy Lipids and lipid-like molecules > Prenol lipids > Sesquiterpenoids
IUPAC Name methyl (4R)-4-[(2S)-6-methyl-4-oxoheptan-2-yl]cyclohexene-1-carboxylate
SMILES (Canonical) CC(C)CC(=O)CC(C)C1CCC(=CC1)C(=O)OC
SMILES (Isomeric) C[C@@H](CC(=O)CC(C)C)[C@@H]1CCC(=CC1)C(=O)OC
InChI InChI=1S/C16H26O3/c1-11(2)9-15(17)10-12(3)13-5-7-14(8-6-13)16(18)19-4/h7,11-13H,5-6,8-10H2,1-4H3/t12-,13-/m0/s1
InChI Key IIWNDLDEVPJIBT-STQMWFEESA-N
Popularity 1 reference in papers

Physical and Chemical Properties

Top
Molecular Formula C16H26O3
Molecular Weight 266.38 g/mol
Exact Mass 266.18819469 g/mol
Topological Polar Surface Area (TPSA) 43.40 Ų
XlogP 3.50
Atomic LogP (AlogP) 3.53
H-Bond Acceptor 3
H-Bond Donor 0
Rotatable Bonds 6

Synonyms

Top
26575-87-1

2D Structure

Top
2D Structure of (+)-Epijuvabione

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.9929 99.29%
Caco-2 + 0.8488 84.88%
Blood Brain Barrier + 0.7750 77.50%
Human oral bioavailability + 0.6571 65.71%
Subcellular localzation Mitochondria 0.7998 79.98%
OATP2B1 inhibitior - 0.8546 85.46%
OATP1B1 inhibitior + 0.9195 91.95%
OATP1B3 inhibitior + 0.9149 91.49%
MATE1 inhibitior - 0.5000 50.00%
OCT2 inhibitior - 0.6750 67.50%
BSEP inhibitior - 0.7833 78.33%
P-glycoprotein inhibitior - 0.9386 93.86%
P-glycoprotein substrate - 0.7423 74.23%
CYP3A4 substrate + 0.5371 53.71%
CYP2C9 substrate - 0.7707 77.07%
CYP2D6 substrate - 0.9060 90.60%
CYP3A4 inhibition - 0.8650 86.50%
CYP2C9 inhibition - 0.8211 82.11%
CYP2C19 inhibition - 0.8132 81.32%
CYP2D6 inhibition - 0.9466 94.66%
CYP1A2 inhibition - 0.8265 82.65%
CYP2C8 inhibition - 0.8226 82.26%
CYP inhibitory promiscuity - 0.7765 77.65%
UGT catelyzed - 0.0000 0.00%
Carcinogenicity (binary) - 0.6471 64.71%
Carcinogenicity (trinary) Non-required 0.6199 61.99%
Eye corrosion - 0.9061 90.61%
Eye irritation + 0.5595 55.95%
Skin irritation - 0.7136 71.36%
Skin corrosion - 0.9969 99.69%
Ames mutagenesis - 0.7300 73.00%
Human Ether-a-go-go-Related Gene inhibition - 0.4372 43.72%
Micronuclear - 0.9300 93.00%
Hepatotoxicity + 0.5140 51.40%
skin sensitisation + 0.5243 52.43%
Respiratory toxicity - 0.5222 52.22%
Reproductive toxicity - 0.7275 72.75%
Mitochondrial toxicity - 0.9375 93.75%
Nephrotoxicity - 0.6215 62.15%
Acute Oral Toxicity (c) III 0.6862 68.62%
Estrogen receptor binding - 0.7311 73.11%
Androgen receptor binding - 0.6608 66.08%
Thyroid receptor binding - 0.5862 58.62%
Glucocorticoid receptor binding - 0.6523 65.23%
Aromatase binding - 0.7642 76.42%
PPAR gamma - 0.7159 71.59%
Honey bee toxicity - 0.8912 89.12%
Biodegradation - 0.6500 65.00%
Crustacea aquatic toxicity - 0.7800 78.00%
Fish aquatic toxicity + 0.9888 98.88%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL4040 P28482 MAP kinase ERK2 99.48% 83.82%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 98.05% 96.09%
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 93.52% 91.11%
CHEMBL2581 P07339 Cathepsin D 91.63% 98.95%
CHEMBL4203 Q9HAZ1 Dual specificity protein kinase CLK4 90.51% 94.45%
CHEMBL2782 P35610 Acyl coenzyme A:cholesterol acyltransferase 1 85.97% 91.65%
CHEMBL221 P23219 Cyclooxygenase-1 85.07% 90.17%
CHEMBL3060 Q9Y345 Glycine transporter 2 84.84% 99.17%
CHEMBL2111367 P27986 PI3-kinase p110-alpha/p85-alpha 84.49% 94.33%
CHEMBL5608 Q16288 NT-3 growth factor receptor 82.23% 95.89%
CHEMBL4208 P20618 Proteasome component C5 81.68% 90.00%
CHEMBL1907603 Q05586 Glutamate NMDA receptor; GRIN1/GRIN2B 81.51% 95.89%

Cross-Links

Top
PubChem 10923485
NPASS NPC190453
LOTUS LTS0163112
wikiData Q105113798